Axcelis Technologies, Inc. (ACLS)
NASDAQ: ACLS · IEX Real-Time Price · USD
141.22
+0.53 (0.38%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Company Description

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Japan, Europe, and Asia Pacific.

The company offers high energy, high current, and medium current implanters for various application requirements.

It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training.

It sells its equipment and services to semiconductor chip manufacturers through its direct sales force.

The company was founded in 1978 and is headquartered in Beverly, Massachusetts.

Axcelis Technologies, Inc.
Axcelis Technologies logo
Country United States
Founded 1995
IPO Date Jul 11, 2000
Industry Semiconductor Equipment & Materials
Sector Technology
Employees 1,704
CEO Dr. Russell J. Low Ph.D.

Contact Details

Address:
108 Cherry Hill Drive
Beverly, Massachusetts 01915
United States
Phone 978-787-4000
Website axcelis.com

Stock Details

Ticker Symbol ACLS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001113232
CUSIP Number 054540208
ISIN Number US0545402085
Employer ID 34-1818596
SIC Code 3559

Key Executives

Name Position
Dr. Russell J. Low Ph.D. Chief Executive Officer, President and Director
Mary G. Puma Executive Chairperson
James G. Coogan Executive Vice President and Chief Financial Officer
Lynnette C. Fallon Executive Vice President of Human Resources and Legal, General Counsel and Corporate Secretary
Gregory F. Redinbo Ph.D. Executive Vice President of Marketing and Applications
Kevin J. Brewer Senior Advisor
Gerald M. Blumenstock Executive Vice President of Engineering
Douglas A. Lawson Executive Vice President of Corporate Marketing and Strategy
Dr. Christopher Tatnall Ph.D. Executive Vice President of Global Customer Operations

Latest SEC Filings

Date Type Title
May 30, 2024 144 Filing
May 20, 2024 144 Filing
May 17, 2024 SD Form - SD
May 9, 2024 8-K Current Report
May 2, 2024 10-Q Quarterly Report
May 1, 2024 8-K Current Report
Mar 29, 2024 ARS Filing
Mar 29, 2024 DEF 14A Other definitive proxy statements
Mar 8, 2024 PRE 14A Other preliminary proxy statements
Mar 7, 2024 144 Filing